For the year ending 2025-12-31, BICX made $797,244 in revenue. -$3,440,146 in net income. Net profit margin of -431.50%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenues, net | 797,244 | 7,665 | ||
| Cost of implants and other costs | 21,802 | - | ||
| Research and development | 1,768,955 | 1,482,877 | ||
| Selling, general and administrative | 3,794,126 | 3,612,481 | ||
| Depreciation and amortization | 44,003 | 33,145 | ||
| Cost of implants and other costs | - | 1,667 | ||
| Total operating expenses | 5,628,886 | 5,130,170 | ||
| Loss from operations | -4,831,642 | -5,122,505 | ||
| Interest expense - related parties | 637,705 | 750,773 | ||
| Interest expense, net | 223,850 | 776,780 | ||
| Loss on settlement of debt | -187,514 | -164,602 | ||
| Grant income | 2,435,848 | - | ||
| Change in fair value of upfront purchase price liability | -7,426 | - | ||
| Change in fair value of royalty liability | -279,511 | - | ||
| Grant income | - | 1,473,276 | ||
| Other miscellaneous income | 223,037 | 129,282 | ||
| Total other (expenses) income, net | 1,322,879 | -89,597 | ||
| Loss before provision for income taxes | -3,508,763 | -5,212,102 | ||
| Income taxes | 0 | - | ||
| Net loss | -3,508,763 | - | ||
| Non-controlling interest | -68,617 | - | ||
| Net loss attributable to biocorrx inc | -3,440,146 | -5,212,102 | ||
| Non-controlling interest | - | 105,978 | ||
| Net loss attributable to biocorrx inc | - | -5,106,124 | ||
| Diluted EPS | -0.19 | - | ||
| Diluted Average Shares | 18,485,888 | 3,378,376 | ||
BioCorRx Inc. (BICX)
BioCorRx Inc. (BICX)